These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 20696818)
21. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor. Lee SE; Jeong IG; Ku JH; Kwak C; Lee E; Jeong JS Urology; 2004 May; 63(5):873-7; discussion 877. PubMed ID: 15134968 [TBL] [Abstract][Full Text] [Related]
22. What is the significance of pT0 at cystectomy? Hotston M; Patel S; Sohail M; Persad RA Surg Oncol; 2006 Aug; 15(2):65-9. PubMed ID: 16971115 [TBL] [Abstract][Full Text] [Related]
23. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Choong NW; Quevedo JF; Kaur JS Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264 [TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800 [TBL] [Abstract][Full Text] [Related]
25. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452 [TBL] [Abstract][Full Text] [Related]
26. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847 [TBL] [Abstract][Full Text] [Related]
27. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy. Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145 [TBL] [Abstract][Full Text] [Related]
28. Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder. Singh PB; Kumar A; Das SK; Pandey AK; Sharma GK; Samir Swain HB; Trivedi S; Dwivedi US Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):881-5. PubMed ID: 20814125 [TBL] [Abstract][Full Text] [Related]
29. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience. Hemal AK; Kolla SB J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813 [TBL] [Abstract][Full Text] [Related]
30. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855 [TBL] [Abstract][Full Text] [Related]
31. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301 [TBL] [Abstract][Full Text] [Related]
32. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
33. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
35. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059 [TBL] [Abstract][Full Text] [Related]
36. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174 [TBL] [Abstract][Full Text] [Related]
37. Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed. Manoharan M; Katkoori D; Kishore TA; Kava B; Singal R; Soloway MS BJU Int; 2009 Dec; 104(11):1646-9. PubMed ID: 19466944 [TBL] [Abstract][Full Text] [Related]
38. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy. Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398 [TBL] [Abstract][Full Text] [Related]
39. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. Herr HW Eur Urol; 2008 Jul; 54(1):126-32. PubMed ID: 18248875 [TBL] [Abstract][Full Text] [Related]